ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $1.8M invested in Enlivex Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$894K
2
+$155K
3
+$56K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$51K
5
UBS Group
UBS Group
Switzerland
+$2K

Top Sellers

1
-$2.18M
2
-$1.85M
3
-$22K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.38M
2
$155K
3
$93K
4
$65K
5
$56K
6
$51K
7
$2K
8
–
9
–